about
Manual lymphatic drainage for lymphedema following breast cancer treatmentNatural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic reviewChemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case reportA pilot study of acupuncture in treating bortezomib-induced peripheral neuropathy in patients with multiple myeloma.New concepts in the treatment of acute myeloid malignancies: selected pathways for targeted therapy.Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond.How we maintain bone health in early-stage breast cancer patients on aromatase inhibitorsPatient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall riskImprovement of Painful Bortezomib-Induced Peripheral Neuropathy Following Acupuncture Treatment in a Case Series of Multiple Myeloma Patients.The National Cancer Institute's Conference on Acupuncture for Symptom Management in Oncology: State of the Science, Evidence, and Research Gaps.State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report.Living with chronic pain: perceptions of breast cancer survivors.Acupuncture versus medication for pain management: a cross-sectional study of breast cancer survivors.Perspectives. "The Doctor".Acupuncture for breast cancer-related lymphedema: a randomized controlled trial.Barriers to Acupuncture Use Among Breast Cancer Survivors: A Cross-Sectional Analysis.Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice GuidelineAromatase, aromatase inhibitors, and breast cancerJoint pain and falls among women with breast cancer on aromatase inhibitorsAcupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just for PainGene expression profiling of breast cancerAdjuvant endocrine therapy for premenopausal women with early breast cancerEffect of simvastatin on the pharmacokinetics of anastrozoleThe analgesic effect of magnetic acupressure in cancer patients undergoing bone marrow aspiration and biopsy: a randomized, blinded, controlled trialA phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patientsPrevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitorsA Technology-Assisted, Brief Mind-Body Intervention to Improve the Waiting Room Experience for Chemotherapy Patients: Randomized Quality Improvement StudyAddressing the Unintentional Consequences of Cancer Therapy With Novel Integrative TherapeuticsChemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testingMethodology Flaws and Implications of a Complementary Medicine StudyUnderstanding the Benefits of Acupuncture Treatment for Cancer Pain Management
P50
Q24187877-CEC94A4C-ECE4-400B-AAF9-78D0CC3DF252Q28270819-2474F669-714B-435E-8F19-D279AB717F83Q33984071-FDEE5141-84CA-4AC4-8169-AA78C05582F2Q35428713-10149863-2781-4392-8617-186F244835EAQ36037229-4C4AA931-63F6-4E51-94C0-B76E2E865C55Q36264333-3FB96807-98B5-4D21-9A27-366A43C8168EQ36542660-0B166957-D200-4ADF-A5A0-5E7A045286F1Q37476554-48EAF0B0-C51F-4B8B-9A83-45A1BA90D9F7Q38870617-5173BCD6-32E0-4AB3-B57F-E8ABEDC0D159Q41009010-F78158D0-80D7-4FA0-9EAE-5C26D0B4306CQ46755854-EE590442-3884-4819-A58E-2F51AE3B66F8Q47217006-30027215-8B73-433A-8585-E2A9647B1E95Q47217032-D523C6E6-33B7-42CA-86FA-035A7B38C31BQ48209604-2AC549D0-1686-4138-873E-0300FF299657Q50027759-E5628FF0-3D98-43BA-9D26-B3E29596BAABQ50997980-C5661DBF-D3F2-4A0D-BDB6-8EDDFE6A560BQ51742517-47FB2B11-FE62-4B58-A0B8-26E139561C2DQ52714058-5C7A6E4A-5D21-4E4D-A97A-1719AF726925Q57107091-3D11A05C-4377-4C1E-9648-BDAC6CFCCC19Q57137315-89543231-DB9E-4464-B9B3-88EB8122A79FQ57286680-3E16151D-EFD8-4403-B02B-418F4FDA62A2Q64325345-4A464192-A03A-4859-B6B8-B36C583DE548Q79709460-DE1F7026-95FB-4CA7-912F-4453EB61B4CBQ80482657-5E84AC3D-1588-4B8E-8DD2-9CBB0571F969Q82536583-510F0242-76F1-42F5-8D1B-7CD7F3060D61Q83392111-F6E6ED59-8FE8-49F4-9379-4747E344A0B1Q90214069-3D0E8FC7-1E9A-4FB7-B568-3B8600803CDDQ90270469-1531BB9F-8F8B-45F6-8082-893E55995AAFQ91162378-56C892CE-89C9-414F-9D39-FE5BE7D1CDB9Q91546509-A4A78FF4-5273-4759-B74F-87C71A23922BQ92915917-889B6BDC-1A08-4415-A5F3-811CB4AB03D5Q95394143-DA327420-B78B-42D6-899E-CA7D30C8011FQ95589797-48346CAB-1F30-4954-8A09-25910EABD605
P50
description
researcher ORCID ID = 0000-0003-4437-2597
@en
wetenschapper
@nl
name
Ting Bao
@ast
Ting Bao
@en
Ting Bao
@es
Ting Bao
@nl
type
label
Ting Bao
@ast
Ting Bao
@en
Ting Bao
@es
Ting Bao
@nl
prefLabel
Ting Bao
@ast
Ting Bao
@en
Ting Bao
@es
Ting Bao
@nl
P31
P496
0000-0003-4437-2597